Ownership

Kevin Koch - President and CEO, Director at Edgewise Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type: Individual
Role: President and CEO, Director
Stock Symbol: EWTX on Nasdaq
Industry: Pharmaceutical Preparations
All Insider Reports: All Insider Reports

Kevin Koch - trading volume in the past year for Edgewise Therapeutics, Inc.

	Shares	%	Avg Price	Total $
Buys
Sells	-12.7K	100%	$27.34	-$347K
Net	-12.7K	-100%		-$347K

Showing 1 to 3 of 3 entries

Holdings reported by Kevin Koch for Edgewise Therapeutics, Inc.

Class	Num Shares	Value	Price $	Transaction Date	Ownership	Underlying Class	Underlying Amount
Common Stock	260K	$8.08M	$31.13	Feb 5, 2025	KTK Family Enterprise, LLC
Restricted Stock Units	71.9K	$1.36M	$18.91	Aug 12, 2024	Direct	Common Stock
Common Stock	26.4K	$822K	$31.13	Feb 5, 2025	Adrienne R. Koch Heritage Trust
Common Stock	26.4K	$822K	$31.13	Feb 5, 2025	Matthew K. Koch Heritage Trust
Common Stock	26.4K	$822K	$31.13	Feb 5, 2025	Nicole M. Soldow Heritage Trust
Common Stock	14.5K	$451K	$31.13	Feb 6, 2025	Direct
Stock Option (Right to Buy)	41.6K			Feb 6, 2025	Direct	Common Stock

Transactions reported by Kevin Koch for Edgewise Therapeutics, Inc.

Sym	Class	Transaction	%	Value $	* Price $	Shares	Shares After	Date	Ownership

* An asterisk sign (*) next to the price indicates that the price is likely invalid.